236 related articles for article (PubMed ID: 23338611)
1. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.
Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M
Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
Meng G; Xia M; Xu C; Yuan D; Schnurr M; Wei J
Int J Cancer; 2014 Apr; 134(8):1958-71. PubMed ID: 23921958
[TBL] [Abstract][Full Text] [Related]
3. 5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma.
Poeck H; Besch R; Maihoefer C; Renn M; Tormo D; Morskaya SS; Kirschnek S; Gaffal E; Landsberg J; Hellmuth J; Schmidt A; Anz D; Bscheider M; Schwerd T; Berking C; Bourquin C; Kalinke U; Kremmer E; Kato H; Akira S; Meyers R; Häcker G; Neuenhahn M; Busch D; Ruland J; Rothenfusser S; Prinz M; Hornung V; Endres S; Tüting T; Hartmann G
Nat Med; 2008 Nov; 14(11):1256-63. PubMed ID: 18978796
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs.
Yuan D; Xia M; Meng G; Xu C; Song Y; Wei J
Oncotarget; 2015 Oct; 6(30):29664-74. PubMed ID: 26336994
[TBL] [Abstract][Full Text] [Related]
5. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
Han Q; Hou Z; Yin C; Zhang C; Zhang J
Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic STAT4 Promotes Antiviral Type I IFN Production by Blocking CHIP-Mediated Degradation of RIG-I.
Zhao K; Zhang Q; Li X; Zhao D; Liu Y; Shen Q; Yang M; Wang C; Li N; Cao X
J Immunol; 2016 Feb; 196(3):1209-17. PubMed ID: 26695369
[TBL] [Abstract][Full Text] [Related]
8. TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells.
Imaizumi T; Aizawa-Yashiro T; Watanabe S; Matsumiya T; Yoshida H; Tatsuta T; Xing F; Meng P; Hayakari R; Tsuruga K; Tanaka H
J Nephrol; 2013; 26(5):886-93. PubMed ID: 23559071
[TBL] [Abstract][Full Text] [Related]
9. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model.
Tai KF; Wang CH
Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745
[TBL] [Abstract][Full Text] [Related]
10. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.
Duewell P; Steger A; Lohr H; Bourhis H; Hoelz H; Kirchleitner SV; Stieg MR; Grassmann S; Kobold S; Siveke JT; Endres S; Schnurr M
Cell Death Differ; 2014 Dec; 21(12):1825-37. PubMed ID: 25012502
[TBL] [Abstract][Full Text] [Related]
11. Dual effects of duplex RNA harboring 5'-terminal triphosphate on gene silencing and RIG-I mediated innate immune response.
Baek SE; Kim H; Kim KB; Yoon S; Choe J; Suh W; Jeong YJ; Cho YH; Kim DE
Biochem Biophys Res Commun; 2015 Jan; 456(2):591-7. PubMed ID: 25490387
[TBL] [Abstract][Full Text] [Related]
12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
13. Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.
Conroy H; Galvin KC; Higgins SC; Mills KH
Cancer Immunol Immunother; 2012 Mar; 61(3):425-31. PubMed ID: 22193988
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells.
Imaizumi T; Tanaka H; Matsumiya T; Yoshida H; Tanji K; Tsuruga K; Oki E; Aizawa-Yashiro T; Ito E; Satoh K
Nephrol Dial Transplant; 2010 Nov; 25(11):3534-9. PubMed ID: 20484300
[TBL] [Abstract][Full Text] [Related]
15. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
16. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
17. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.
Das M; Shen L; Liu Q; Goodwin TJ; Huang L
Mol Ther; 2019 Mar; 27(3):507-517. PubMed ID: 30545600
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
20. Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice.
Zhang Y; Li L; Yu J; Zhu D; Zhang Y; Li X; Gu H; Zhang CY; Zen K
Biomaterials; 2014 May; 35(14):4390-400. PubMed ID: 24565517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
